A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

In a randomized clinical trial, gemcitabine (GEM) was more effective than 5-fluorouracil (5-FU) in advanced pancreatic cancer patients. GEM and 5-FU have different mechanisms of action and their combination, from a theoretical point of view, could result in a higher activity. To test activity and fe...

Descripción completa

Detalles Bibliográficos
Autores principales: Cascinu, S, Silva, R R, Barni, S, Labianca, R, Frontini, L, Piazza, E, Pancera, G, Giordani, P, Giuliodori, L, Pessi, M A, Fusco, V, Luporini, G, Cellerino, R, Catalano, G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363090/
https://www.ncbi.nlm.nih.gov/pubmed/10408405
http://dx.doi.org/10.1038/sj.bjc.6690568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363090/
https://www.ncbi.nlm.nih.gov/pubmed/10408405
http://dx.doi.org/10.1038/sj.bjc.6690568

Ejemplares similares